SciTransfer
Organization

DUPONT NUTRITION BIOSCIENCES APS

Global specialty ingredients company (formerly Danisco) with expertise in animal feed formulation and antimicrobial food safety science.

Large industrial companyfoodDKNo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
0
Total EC funding
€179K
Unique partners
40
What they do

Their core work

DuPont Nutrition & Biosciences APS is the Danish subsidiary of the global specialty ingredients company DuPont, operating from Copenhagen under the legacy of Danisco — one of the world's leading producers of food enzymes, emulsifiers, probiotics, and animal nutrition ingredients. In H2020 research, they participate as an industry partner bringing commercial-scale formulation knowledge, product testing infrastructure, and direct routes to market that academic consortia typically lack. Their project participation spans optimizing livestock feed for efficiency and sustainability, and more recently investigating antimicrobial materials and biofilm disruption — both areas with clear commercial relevance to their ingredient and food safety portfolios. They function as an industrial anchor in research consortia, contributing applied expertise and validating that emerging science can translate into manufacturable products.

Core expertise

What they specialise in

Animal nutrition and feed efficiencyprimary
1 project

In Feed-a-Gene (2015-2020), DuPont NB contributed as a funded participant to a project adapting feed formulation, genetics, and feeding techniques for pigs, poultry, and rabbits to improve efficiency and sustainability.

Precision feeding and livestock production systemsprimary
1 project

Feed-a-Gene covered precision feeding, feed processing, use of local resources and by-products, and consumer acceptance — all areas aligned with DuPont's commercial animal nutrition ingredient business.

Antimicrobial surfaces and biofilm controlemerging
1 project

BREAK BIOFILMS (2019-2023) engaged them as a third-party partner in research on nanoantimicrobials, biofilm disruption, nanoelectrochemistry, and ultrasensitive bacterial detection on surfaces.

Food and feed ingredients formulationsecondary
1 project

Their participation in feed processing and by-product utilization within Feed-a-Gene reflects their broader commercial role as a global supplier of functional ingredients to the food and feed industries.

Evolution & trajectory

How they've shifted over time

Early focus
Precision animal feed optimization
Recent focus
Antimicrobial biofilm science

In their early H2020 period (2015-2020), DuPont NB was firmly rooted in applied animal nutrition — precision feeding, feed processing, efficient use of local and by-product ingredients, and genetics-informed livestock production for pigs, poultry, and rabbits. Their second project (2019-2023) represents a marked thematic shift into antimicrobial materials science: biofilm disruption, nanoantimicrobials, nanoelectrochemistry, and ultrasensitive bacterial detection — a domain quite distant from feed formulation. This pivot may reflect the company's broader food safety and hygiene ingredient portfolio (antimicrobial enzymes, surface-active compounds), suggesting they are actively scouting materials science advances with potential application in food processing environments.

DuPont NB appears to be extending its research engagement beyond core animal nutrition into antimicrobial surface and nanomaterial science, likely tracking commercial opportunities in food safety, hygiene, and processing environment control.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European11 countries collaborated

DuPont NB has not led any H2020 project, consistently joining as a participant or third-party partner within consortia led by academic or research institutions. Despite only two projects, they have collaborated with 40 distinct partners across 11 countries, indicating they enter large, pan-European consortia rather than small bilateral arrangements. This pattern is typical of large multinationals using EU research participation to monitor emerging technologies, co-develop solutions, and build academic relationships — without committing to the overhead of project coordination.

Across just two projects, DuPont NB has connected with 40 unique consortium partners spanning 11 countries, reflecting the broad international consortia they join as an industry partner. Their network is pan-European in reach, with no single geographic concentration evident from the available data.

Why partner with them

What sets them apart

DuPont Nutrition & Biosciences brings rare industrial weight to EU research consortia: as the successor to Danisco — historically one of the world's largest producers of food enzymes and emulsifiers — they carry deep commercial expertise and the manufacturing scale needed to take research results into real products. For consortium builders, they offer what most partners cannot: direct access to global ingredient supply chains, established regulatory pathways for food and feed applications, and credibility with industry end-users. Their dual presence in livestock nutrition and antimicrobial science makes them an unusual bridge between food production efficiency and food safety research.

Notable projects

Highlights from their portfolio

  • Feed-a-Gene
    Their only directly EC-funded H2020 project, and the clearest evidence of their core commercial competency — precision animal nutrition — applied within a large multi-partner European research consortium.
  • BREAK BIOFILMS
    Notable for the sharp thematic departure from feed science into nanoantimicrobials and biofilm disruption, signaling a strategic interest in materials-based food safety solutions outside their traditional ingredient focus.
Cross-sector capabilities
Animal health and veterinary nutritionMicrobiology and food safetyAntimicrobial materials and surface scienceBioprocessing and enzyme technology
Analysis note: Profile is based on only 2 projects; DuPont NB's actual commercial capabilities far exceed what is visible in H2020 data. The BREAK BIOFILMS project lists them as a third-party partner with no direct EC funding, suggesting a minor or advisory role rather than full consortium membership. The thematic gap between the two projects is real but may reflect corporate portfolio breadth rather than a genuine strategic pivot. Confidence is limited by data volume — further enrichment from company sources would significantly improve this profile.